← Leaderboards
Andreas Markus Loening
Stanford University
$626,206
Attributed
$626,206
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $234.8K · FY2019–21$250K$187.5K$125K$62.5K$0
'19
'20
'21
Funding mix
By agency
NIH$626,206 · 1
By mechanism
R21$626,206 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Thomas D Wang$22,418,344
- James D Brooks$12,828,912
- Jianghong Rao$21,022,312
- Katherine W Ferrara$45,937,231
- Jonathan R Pollack$9,181,908
Others in their field
Other Emerging Leaders on “Apoptosis”
- Deanna A Kulpa · Emory University$8,444,989
- Yamuna Krishnan · University Of Chicago$5,740,000
- Peter J Leary · University Of Washington$5,643,326
- Tanya Christineh Petrossian · Endomet Biosciences, Inc$4,570,776
- Yanbo Fan · University Of Cincinnati$4,484,838
- William Raymond Lagor · Baylor College Of Medicine$4,366,036
Research focus
ApoptosisAreaBaseBenign Prostatic HypertrophyBiodistributionBiologicalBurden Of IllnessCancer DetectionCancer EtiologyCancer ModelCancer PatientCasp3 GeneCell Culture TechniquesCell DeathCellsCessation Of LifeChemistryCleaved CellClinical ResearchContrast EnhancedContrast MediaDensityDepositionAlgorithms
Grant awards (3)
PSMA activatable MRI contrast agents to improve the detection of prostate cancer$195,696
R21 · FY2021 · EB · contact PI
PSMA activatable MRI contrast agents to improve the detection of prostate cancer$195,694
R21 · FY2020 · EB · contact PI
PSMA activatable MRI contrast agents to improve the detection of prostate cancer$234,816
R21 · FY2019 · EB · contact PI